Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-09-28

FDA Approved: MORPHINE SULFATE EXTENDED RELEASE — Supplemental Application (Rhodes Pharmaceuticals L. P.)

View source ↗

Summary

The FDA approved a supplemental application for Morphine Sulfate Extended Release from Rhodes Pharmaceuticals L.P., updating labeling to support long-term manag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE)

Snippet

SUPPL AP for MORPHINE SULFATE EXTENDED RELEASE (MORPHINE SULFATE)